Mail & Guardian
Mail & Guardian
antiretroviralslatest news & developments
In many regions, human–water systems are already in a post-crisis state of failure. Photo: Delwyn Verasamy

Traces of ARVs in drinking water ‘harmless’ but can affect health over time

Pharmaceutical contaminants in water are a growing risk, warns the Water Research Commission

Local pharmaceutical production would help insulation against external shocks, which hurts vulnerable people the most.

US aid cuts: Africa must make its own medicine

Donald Trump’s funding freeze underlines that South Africa needs to prioritise the development of its pharmaceutical manufacturing sector

The government’s Aids policies sparked protests like the one pictured in 2001 in Cape Town. (Per-Anders Pettersson / Getty Images)

How the Constitution changed the HIV/Aids epidemic’s trajectory in SA

Treatment Action Campaign and other civil society groups forced a reluctant Mbeki government to change its stance and roll out ARVs

Prevention and treatment: Selena Bishop attends a consultation at Sorgin Health Centre in Nsanje, Malawi. Bishop is HIV positive is collecting her ARV refill. New research has found a bimonthly injection to be highly effective in preventing new HIV infections. Photo: Luca Sola

Six injections a year could stop new HIV infections

New research from seven countries in Africa signals the future of HIV prevention — but what can it learn from its past?

(Delwyn Verasamy/M&G)

Eusebius McKaiser: A witness to Covid-19 stigma

Let us please not repeat the devastating Aids story where people died of shame rather than admit being infected by the virus

Despite the long history of medical racism, any potential Covid-19 vaccines must be tested in Africa — but not only on the continent. (Reuters)

My late uncle, and the ethics of clinical trials in Africa

Despite the long history of medical racism, any potential Covid-19 vaccines must be tested in Africa — but not only on the continent

(John McCann/M&G)

The quest for the (vaginal) ring

The HIV prevention tablet is now available in South Africa but popping a pill every day to stay HIV-negative may not be for everyone

They’re not only good for workers’ health

On the road: Go inside the farm clinics making sure workers are never far from care

They’re not only good for workers’ health, they’re good for business too.

The apparent benefits of the internship model need to be offset by operational, political and academic challenges

Research: More than 50 000 teachers at public schools are living with HIV

The purpose of the research was to look at the health and wellbeing of public schools, with specific focus on the HIV profile of school leadership

Keita is a central midfielder comfortable in either half of the pitch.

Will South Africa reach its 90-90-90 HIV targets?

The country has made progress with its plans to prevent, treat and monitor HIV but still has a long way to go.

Fela Gucci: “We’re already trying to survive so much”.

Six ways ARVs can help to end Aids by 2030

Science knows more than ever about how to use HIV treatment to prevent new infections but will it be enough to end Aids?

Charges in sub-Saharan Africa average 12% on transfers of $200

Health financing crisis threatens developing countries, experts say

Researchers predict that in 2040, low-income countries will spend just $0.03 on healthcare for every dollar that high-income countries spend.

Why Africa needs PrEP: A two-in-one pill to prevent HIV infection

Truvada, which contains two antiretrovirals, reduces the risk of HIV infection with up to 96%.

SSP found that the Free State’s medicine supply was in a state of ‘provincial emergency’ after finding that all six facilities it surveyed between May and July in six sub districts experienced drug stock-outs of essential medicines.

Survey uncovers shortages in critical medication

A survey of stock levels of HIV drugs is in stark contrast to health department claims that "there is no shortage".

The TAC applied successfully to the Constitutional Court for the state to provide antiretrovirals for free to people living with HIV and Aids

Funding crunch threatens TAC

Aids is not over, says Archbishop Emeritus Desmond Tutu, but donors are pulling out of South Africa because it is a middle-income country.

Ginkgo Biloba leaves.

Health-fad herb may reduce ARV efficacy, report warns

Experts believe Ginkgo biloba, a natural product used in vitamin supplements, may be harmful if taken together with HIV medication.

How true are reports of breakthrough Aids ‘cures’?

As the world recently marked World Aids Day, Africa Check has investigated the evidence behind three claims of an Aids breakthrough "cure".

Sanac hopes for three-million on ARVs by 2015

The South African National Aids Council says it aims to have three million people receiving antiretroviral therapy by 2015.

‘Early treatment’ breakthrough in HIV research

Early antiretroviral therapy reduces HIV transmission by 96%, Wits University announced on Thursday, following a multi-centre study.

Motlanthe commemorates World Aids Day

More than 4,6-million South Africans took an HIV test since April, Deputy President Kgalema Motlanthe said at a World Aids Day event in Mpumalanga.